Retsevmo 40 mg, comprimés pelliculés

7680702140018 CH-70214 Tabletten

No image available

Article details

Package size
56
Selling units
56
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/08/2026
Patient information leaflet
Français
03/08/2026
Patient information leaflet
Italien
03/08/2026
Summary of Product Characteristics
Allemand
03/08/2026
Summary of Product Characteristics
Français
03/08/2026
Summary of Product Characteristics
Italien
03/08/2026

Detailed composition

Substance Quantity Type Category
selpercatinibum
40.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
mannitolum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
natrium
0.654 MG Substance HBESI

Reimbursement information

Public price
CHF 1560.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
70214
Drug name
Retsevmo, comprimés pelliculés
Galenic form
FILM
ATC Code
L01EX22
Authorization status
Z
Dispensing category
A
First authorization
21/05/2026
Authorization expiration date
20/05/2031
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
RETSEVMO cpr pellic 40 mg 56 pce
Description (DE)
RETSEVMO Filmtabl 40 mg 56 Stk
Market launch
01/08/2026
Narcotic (BTM)
No

Other package sizes (1)

RETSEVMO cpr pellic 80 mg 56 pce
56 TABL
GTIN: 7680702140025
View
Buy us a coffee Explore the data